Expertise in
3
conditions

Alan M. Nichol

BC Cancer Victoria
Victoria, BC, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
BC Cancer Victoria
Victoria, BC, CA 

Overview

Alan Nichol practices practicing medicine in Victoria, Canada.

Mr. Nichol is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Brain Tumor, Anal Cancer, Angiosarcoma, and Mastectomy.

He is actively involved in clinical research, co-authoring 93 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

BC Cancer Victoria
Victoria, BC, Canada
Other Locations
Vancouver Island Centre, Victoria, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Randomized Phase II Non-Inferiority Study of 5-Day Versus 1-Day RAPid SimPLE (RAPPLE) Targeted Radiation Treatment for Brain Metastases
Randomized Phase II Non-Inferiority Study of 5-Day Versus 1-Day RAPid SimPLE (RAPPLE) Targeted Radiation Treatment for Brain Metastases
Enrollment Status: Recruiting
Publish Date: April 17, 2025
Intervention Type: Radiation
Study Phase: Phase 2
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 3
A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
A Phase II Study of Whole Brain Radiotherapy With Simultaneous Integrated Boost Using Volumetric Modulated Arc Therapy for One to Ten Brain Metastases
A Phase II Study of Whole Brain Radiotherapy With Simultaneous Integrated Boost Using Volumetric Modulated Arc Therapy for One to Ten Brain Metastases
Enrollment Status: Unknown
Publish Date: August 14, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
Cancer DNA Screening Pilot Study (CANDACE)
Cancer DNA Screening Pilot Study (CANDACE)
Enrollment Status: Completed
Publish Date: August 24, 2020
Intervention Type: Genetic
Study Phase: Not Applicable
A Randomized Phase II Study of 20 Gy in 5 Fractions Whole Brain Radiotherapy Versus 15 Gy in 1 Fraction Volumetric Modulated Arc Therapy for One to Ten Brain Metastases
A Randomized Phase II Study of 20 Gy in 5 Fractions Whole Brain Radiotherapy Versus 15 Gy in 1 Fraction Volumetric Modulated Arc Therapy for One to Ten Brain Metastases
Enrollment Status: Completed
Publish Date: May 20, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
View 6 Less Clinical Trials

93 Total Publications

Author's response to Letter to the Editor "causes of death in older patients with high-risk breast cancer: What are the most significant contributors?"
Author's response to Letter to the Editor "causes of death in older patients with high-risk breast cancer: What are the most significant contributors?"
Journal: Journal of geriatric oncology
Published: April 03, 2026

Frequently Asked Questions about Alan M. Nichol

Is Alan M. Nichol a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alan M. Nichol is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alan M. Nichol participate in research or clinical trials?

Yes. Alan M. Nichol has published 93 articles and abstracts on conditions like Breast Cancer. You can view a list of Alan M. Nichol's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nichol's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile